Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma. (Q38153283)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

F Massari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Massimo Nabissi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Giampaolo Tortora

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Stefano Cascinu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Matteo Santoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Consuelo Amantini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Francesca Maines

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Luciano Burattini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Giorgio Santoni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Rodolfo Montironi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

17 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1757-1768

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Differential macrophage programming in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Tumor-associated macrophages in clear cell renal cell carcinoma express both gastrin-releasing peptide and its receptor: a possible modulatory role of immune effectors cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Orchestration of metabolism by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

TNF-alpha in promotion and progression of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

TGF-beta promotes the establishment of renal cell carcinoma bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

The notch and TGF-β signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Expression of bone morphogenetic proteins, the subfamily of the transforming growth factor-beta superfamily, in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Effect of bone morphogenetic protein-6 on macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Mammalian autophagy: core molecular machinery and signaling regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

The regulation of autophagy - unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Autophagy fights disease through cellular self-digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Proper macrophagic differentiation requires both autophagy and caspase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Sorafenib induces autophagy and suppresses activation of human macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma--results from a randomised phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Present and future of tyrosine kinase inhibitors in renal cell carcinoma: analysis of hematologic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Tumour macrophages as potential targets of bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Type I interferons inhibit the generation of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

"Re-educating" tumor-associated macrophages by targeting NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-α-induced human renal carcinoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1487-6

10.1007/S00262-013-1487-6

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 February 2020

1031625947

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132754%20AND%20SRC:MED&resulttype=core&format=json